SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 69 filers reported holding SAVARA INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,007,723 | +54.9% | 7,938,551 | +30.9% | 0.07% | +61.9% |
| Q2 2023 | $19,376,240 | +44.8% | 6,064,551 | -11.7% | 0.04% | +40.0% |
| Q1 2023 | $13,385,874 | +25.8% | 6,864,551 | 0.0% | 0.03% | +20.0% |
| Q4 2022 | $10,640,054 | +0.0% | 6,864,551 | 0.0% | 0.02% | -3.8% |
| Q3 2022 | $10,640,000 | +2.0% | 6,864,551 | 0.0% | 0.03% | +8.3% |
| Q2 2022 | $10,434,000 | +16.0% | 6,864,551 | 0.0% | 0.02% | +41.2% |
| Q1 2022 | $8,993,000 | +5.7% | 6,864,551 | 0.0% | 0.02% | +13.3% |
| Q4 2021 | $8,512,000 | -10.1% | 6,864,551 | 0.0% | 0.02% | -21.1% |
| Q3 2021 | $9,473,000 | -18.8% | 6,864,551 | 0.0% | 0.02% | -17.4% |
| Q2 2021 | $11,670,000 | -23.1% | 6,864,551 | -5.9% | 0.02% | -25.8% |
| Q1 2021 | $15,177,000 | +3199.3% | 7,296,551 | +1724.1% | 0.03% | +3000.0% |
| Q4 2020 | $460,000 | +5.5% | 400,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $436,000 | -56.2% | 400,000 | 0.0% | 0.00% | -66.7% |
| Q2 2020 | $996,000 | +17.5% | 400,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $848,000 | -52.7% | 400,000 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $1,792,000 | +69.1% | 400,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $1,060,000 | +11.8% | 400,000 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $948,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |